From Medscape Gastroenterology

Medscape Medical News from

The Liver Meeting 2014: American Association for the Study of Liver Diseases (AASLD)

November 07 - 11, 2014; Boston, Massachusetts

Conference News

AASLD High Survival Rate With Tumor Downstaging Before Transplant
Medscape Medical News, November 19, 2014
AASLD Enzyme Replacement Cuts Liver Injury in LAL Deficiency
Medscape Medical News, November 18, 2014
AASLD Bariatric Surgery Reduces Steatohepatitis
Medscape Medical News, November 17, 2014
AASLD STOPAH: Only Steroid Reduces Alcoholic Hepatitis Death Risk
Medscape Medical News, November 14, 2014
AASLD Ledipasvir Sofosbuvir Combination Cuts Cirrhotic Hepatitis C
Medscape Medical News, November 13, 2014

AASLD CORAL-1: Post-Transplant Hep C Yields to Oral Combination
Medscape Medical News, November 12, 2014
AASLD Living Donor Transplants No Longer 'Last Resort'
Medscape Medical News, November 11, 2014
AASLD Good Old Aspirin Might Protect Against Liver Fibrosis
Medscape Medical News, November 10, 2014
AASLD Preop Factors Affect CVD Risk After Liver Transplant
Medscape Medical News, November 9, 2014
AASLD What's Hot at the Liver Meeting 2014
Medscape Medical News, November 4, 2014

Medscape Gastroenterology© WebMD, LLC

Expert Commentary

Top Highlights in Hepatology: The Liver Meeting 2014
William F. Balistreri, MD
Hepatitis B Highlights: The Liver Meeting 2014
William F. Balistreri, MD
Top Highlights in NAFLD/NASH: The Liver Meeting 2014
William F. Balistreri, MD
A Future Without Hepatitis C?
William F. Balistreri, MD

Previous Coverage